back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-10-06 18:46 Tx date 2025-10-03 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kazemzadeh, Farnoud
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,000,000 | |
| Filed 2025-10-06 18:45 Tx date 2025-10-01 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kazemzadeh, Farnoud
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-03 14:44 Tx date 2025-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
2,175,000 | |
| Filed 2025-06-03 14:43 Tx date 2025-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
Taghva, Seyed Ali
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
| Filed 2025-06-03 14:41 Tx date 2025-03-21 |
$MDMA
Pharmala Biotech Holdings Inc. |
Taghva, Seyed Ali
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-03 14:39 Tx date 2025-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
1,100,000 | |
| Filed 2025-06-03 14:38 Tx date 2025-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
Avery, William Edward Keith
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
| Filed 2025-06-03 14:36 Tx date 2025-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
Slassi, Abdelmalik
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
| Filed 2025-06-03 14:24 Tx date 2025-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
de Wit, Harriet
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
150,000 | |
| Filed 2025-06-03 14:17 Tx date 2025-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
Tsergas, Perry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
200,000 | |
| Filed 2025-06-03 14:16 Tx date 2025-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
200,000 | |
| Filed 2025-06-03 14:14 Tx date 2025-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
Roy, Kevin Joseph Sylvio
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
400,000 | |
| Filed 2025-06-03 14:12 Tx date 2025-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
250,000 | |
| Filed 2025-05-01 15:54 Tx date 2025-04-30 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: NKO Consulting Corp. (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
+500,000 vol |
5,402,778 | |
| Filed 2025-05-01 15:53 Tx date 2025-04-30 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-500,000 vol |
500,000 | |
| Filed 2025-04-11 11:30 Tx date 2025-03-21 |
$MDMA
Pharmala Biotech Holdings Inc. |
Taghva, Seyed Ali
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2025-03-20 12:47 Tx date 2025-03-17 |
$MDMA
Pharmala Biotech Holdings Inc. |
Avery, William Edward Keith
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-250,000 vol |
750,000 | |
| Filed 2025-03-20 12:46 Tx date 2024-10-01 |
$MDMA
Pharmala Biotech Holdings Inc. |
Avery, William Edward Keith
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-03-20 12:46 Tx date 2025-03-17 |
$MDMA
Pharmala Biotech Holdings Inc. |
Avery, William Edward Keith
5 - Senior Officer of Issuer
Holder: Avery Professional Corporation (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
+250,000 vol |
250,000 | |
| Filed 2025-03-20 12:45 Tx date 2024-10-01 |
$MDMA
Pharmala Biotech Holdings Inc. |
Avery, William Edward Keith
5 - Senior Officer of Issuer
Holder: Avery Professional Corporation (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|